Taken together, our findings reveal a novel oncogenic read-through transcript and its functions in HNSCC cell proliferation and survival, implicating JMJD7-PLA2G4B as a potential target for cancer therapy. This evidence concerns the gene JMJD7 and head and neck squamous cell carcinoma.